We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
Cap. Flow
+$3.24B
Cap. Flow %
0.88%
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.69B
2
NOW icon
ServiceNow
NOW
+$651M
3
AMAT icon
Applied Materials
AMAT
+$563M
4
V icon
Visa
V
+$536M
5
CCL icon
Carnival Corporation Ltd
CCL
+$523M

Sector Composition

Rank Sector Weight
1 Technology 30.9%
2 Financials 11.41%
3 Consumer Discretionary 10.18%
4 Industrials 9.65%
5 Healthcare 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFTX
1376
Definium Therapeutics
DFTX
$5.73B
$13.2M ﹤0.01%
698,130
+421,676
+153% +$7.16M
IRTC icon
1377
iRhythm Holdings
IRTC
$3.59B
$13.2M ﹤0.01%
111,732
-21,943
-16% -$3.17M
SMG icon
1378
ScottsMiracle-Gro
SMG
$4.03B
$13.2M ﹤0.01%
216,755
+7,204
+3% +$466K
TXNM
1379
TXNM Energy Inc
TXNM
$6.47B
$13.2M ﹤0.01%
225,265
+2,595
+1% +$153K
ARW icon
1380
Arrow Electronics
ARW
$10.9B
$13.1M ﹤0.01%
91,516
-27,717
-23% -$3.8M
STWD icon
1381
Starwood Property Trust
STWD
$6.12B
$13.1M ﹤0.01%
761,291
-365,662
-32% -$6.56M
ATR icon
1382
AptarGroup
ATR
$8.45B
$13.1M ﹤0.01%
103,867
+3,056
+3% +$398K
DYN icon
1383
Dyne Therapeutics
DYN
$4.04B
$13M ﹤0.01%
718,333
+97,023
+16% +$1.67M
FCN icon
1384
FTI Consulting
FCN
$4.82B
$13M ﹤0.01%
73,499
+720
+1% +$123K
CHE icon
1385
Chemed
CHE
$6.78B
$13M ﹤0.01%
34,393
+101
+0.3% +$43.3K
OBK icon
1386
Origin Bancorp
OBK
$1.66B
$13M ﹤0.01%
313,348
+37,627
+14% +$1.57M
OMCL icon
1387
Omnicell
OMCL
$1.86B
$13M ﹤0.01%
388,648
-1,130
-0.3% -$47.3K
HRB icon
1388
H&R Block
HRB
$5.18B
$12.9M ﹤0.01%
407,885
-273,824
-40% -$9.54M
VAL icon
1389
Valaris
VAL
$5.51B
$12.9M ﹤0.01%
132,017
-14,581
-10% -$1.14M
IOVA icon
1390
Iovance Biotherapeutics
IOVA
$2.23B
$12.9M ﹤0.01%
3,664,278
+2,278,290
+164% +$7.29M
CSTL icon
1391
Castle Biosciences
CSTL
$749M
$12.8M ﹤0.01%
522,127
-2,554
-0.5% -$83.7K
KN icon
1392
Knowles
KN
$3.22B
$12.8M ﹤0.01%
498,627
-49,176
-9% -$1.24M
XMTR icon
1393
Xometry
XMTR
$4.77B
$12.8M ﹤0.01%
313,135
-57,459
-16% -$3.05M
EWY icon
1394
iShares MSCI South Korea ETF
EWY
$21.7B
$12.8M ﹤0.01%
103,870
+19,670
+23% +$2.46M
MIDD icon
1395
Middleby
MIDD
$6.05B
$12.8M ﹤0.01%
96,207
+389
+0.4% +$59K
JBS
1396
JBS N.V.
JBS
$40.4B
$12.8M ﹤0.01%
709,954
-23,085
-3% -$359K
AIP icon
1397
Arteris
AIP
$1.4B
$12.7M ﹤0.01%
773,857
+36,576
+5% +$580K
RUSHA icon
1398
Rush Enterprises Class A
RUSHA
$5.95B
$12.7M ﹤0.01%
191,632
-760
-0.4% -$50K
TPH
1399
DELISTED
Tri Pointe Homes
TPH
$12.6M ﹤0.01%
270,450
-713,662
-73% -$29M
NRIX icon
1400
Nurix Therapeutics
NRIX
$2.43B
$12.6M ﹤0.01%
812,601
+28,192
+4% +$467K

Similar funds

Nuveen's Q1 2026 Portfolio in Review

As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
  • Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
  • Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
  • Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
  • Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
  • Nuveen opened 48 new positions and closed 76 in Q1 2026.
  • Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.